Cerus Corp Appoints New CMO, Dr. Yu, as Dr. Benjamin Departs
Ticker: CERS · Form: 8-K · Filed: Feb 6, 2025 · CIK: 1020214
| Field | Detail |
|---|---|
| Company | Cerus Corp (CERS) |
| Form Type | 8-K |
| Filed Date | Feb 6, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-change, cmo, personnel
TL;DR
New CMO at Cerus Corp! Dr. Yu takes over from Dr. Benjamin, effective Feb 2, 2025.
AI Summary
Cerus Corporation announced on February 2, 2025, the departure of Dr. Richard M. Benjamin as Chief Medical Officer. The company also announced the appointment of Dr. Michael H. Z. Yu as the new Chief Medical Officer, effective February 2, 2025. Additionally, the company reported on compensatory arrangements for its named executive officers.
Why It Matters
This filing details significant changes in Cerus Corporation's executive leadership, specifically the Chief Medical Officer role, which could impact the company's strategic direction and product development in the medical device sector.
Risk Assessment
Risk Level: medium — Changes in key executive positions like Chief Medical Officer can introduce uncertainty regarding future strategy and operational execution.
Key Players & Entities
- Cerus Corporation (company) — Registrant
- Dr. Richard M. Benjamin (person) — Departing Chief Medical Officer
- Dr. Michael H. Z. Yu (person) — Appointed Chief Medical Officer
- February 02, 2025 (date) — Effective date of changes
FAQ
Who has been appointed as the new Chief Medical Officer of Cerus Corporation?
Dr. Michael H. Z. Yu has been appointed as the new Chief Medical Officer of Cerus Corporation.
When was the appointment of the new Chief Medical Officer effective?
The appointment of Dr. Michael H. Z. Yu as Chief Medical Officer was effective February 02, 2025.
Who is the departing Chief Medical Officer?
Dr. Richard M. Benjamin is the departing Chief Medical Officer.
What is the principal executive office address for Cerus Corporation?
The principal executive office address for Cerus Corporation is 1220 Concord Avenue, Suite 600, Concord, California 94520.
What is the filing date of this Current Report on Form 8-K?
The filing date of this Current Report on Form 8-K is February 06, 2025.
Filing Stats: 445 words · 2 min read · ~1 pages · Grade level 13.2 · Accepted 2025-02-06 16:02:40
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share CERS The Nasdaq Stock Mar
Filing Documents
- cers-20250202.htm (8-K) — 37KB
- 0000950170-25-015365.txt ( ) — 144KB
- cers-20250202.xsd (EX-101.SCH) — 23KB
- cers-20250202_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CERUS CORPORATION Date: February 6, 2025 By: /s/ Chrystal N. Jensen Chrystal N. Jensen Chief Legal Officer and General Counsel